We can’t show the full text here under this license.
Abstract
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) may improve female fertility by stimulating ovulation.
- Infertility rates are increasing due to sociocultural trends, lifestyle factors, and health problems.
- Obesity disrupts ovulation, contributing to rising infertility, particularly among women.
- While GLP-1RAs are used for obesity and type 2 diabetes, their impact on female fertility is not fully understood.
- The effects of GLP-1RAs on the endometrium, which is crucial for embryo implantation, require further investigation.
- Research is needed to explore the safety and developmental outcomes for children born to women conceiving during GLP-1RA treatment.
Simplified